Such data is consistent with previous studies identifying PPARα as a key regulatory node in lipid metabolism and in diseases manifesting steatosis.50,51 However, the specific role of PPARα in the pathogenesis and progression of steatosis is confounded by conflicting reports in the literature. The gene discussed is PPARA; the disease is steatosis.